1461093453-de1c182b-ddcf-43c5-a1c7-1f7b64ff07f6

1. A method of manufacturing a solid-state imaging device comprising the steps of:
providing a pixel array including a plurality of pixel circuits arranged in a matrix, each pixel circuit configured to convert a light signal into an electric signal and store the electric signal according to an exposure time; and
providing a pixel drive unit configured to drive the pixel array to perform a reset of the pixel array, a signal storage, and an output operation,
wherein,
the pixel drive unit includes a pixel reset control portion to supply a signal for resetting a pixel to the pixel circuits of a plurality of rows, and
the pixel reset control portion performs a reset control so that a row in which the reset signal is cancelled and a row in which the reset signal is continued always exist in one reset row change operation, and a row in which the reset signal continues to be supplied exists during two or more reset row change operations before start of an exposure period.
2. The method according to claim 1, wherein a time interval of the reset row change operation in the reset control is constant.
3. The method according to claim 1, wherein a time interval of the reset row change operation in the reset control varies.
4. The method according to claim 1, wherein a time interval of the reset row change operation in the reset operation is not constant.
5. The method according to claim 1, wherein a time interval of the reset row change operation in the reset operation varies partly or entirely.
6. The method according to claim 1, wherein:
the pixel drive unit includes a shift register for designating a reset row, the shift register designates a plurality of reset rows by inputting continuous row designating signals, and
the reset row change operation is a shift operation of the shift register.
7. The method according to claim 6, wherein:
the pixel drive unit performs an output control of the signal for resetting the pixel so that a shift-in of the row designating signal to the shift register is performed in synchronization with a shift clock so as to be sequentially shifted,
the row in which the reset signal is canceled and the row in which the reset signal is continued always exists in one reset row change operation, and
the row in which the reset signal continues to be supplied exists during two or more reset row change operations.
8. The method according to claim 1, wherein the pixel drive unit includes a circuit for designating a single or a plurality of row addresses, and propagates a designation signal outputted by the circuit to another row to designate a plurality of reset rows.
9. The method according to claim 8, wherein the circuit for designating the row address includes a shift register.
10. The method according to claim 8, wherein the circuit for designating the row address includes an address decoder of a combination logic circuit.
11. A method for manufacturing a camera system comprising the steps of:
providing a solid-state imaging device including (i) an optical system for forming a photographic subject image at the imaging device (ii) a signal processing circuit for processing an output image signal of the imaging device,
wherein,
the solid-state imaging device includes a pixel array including a plurality of pixel circuits arranged in a matrix, wherein each of the pixel circuits converts a light signal into an electric signal and stores the electric signal according to an exposure time, and a pixel drive circuit configured to drive the pixel array to perform a reset of the pixel array, a signal storage, and an output operation;
the pixel drive unit includes a pixel reset control portion to supply a signal for resetting a pixel to the pixel circuits of a plurality of rows, and
the pixel reset control portion is performed so that a row in which the reset signal is canceled and a row in which the reset signal is continued always exist in one reset row change operation, a row in which the reset signal continues to be supplied exists during two or more reset row change operations before start of an exposure period.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1-17. (canceled)
18. Use of composition containing
at least one saline chloride compound in the form of a salt of an alkali or an alkaline earth metal and at least one suitable oxidation means for the in situ production of chlorine during the dissolution of the composition in an aqueous solution, where the oxidation potential of the oxidation means in an aqueous solution is higher than the oxidation potential of Cl1C1\xb0 at least in the claimed range,
an acid in such quantity that the composition dissolved in a certain quantity of an aqueous solution will produce a pH-valve of less than 6, preferably less than 5.5 and even more preferably less than 5, as well as
whenever appropriate, a surface-active substance (tenside) or substance mixture, aromatic substance adjuvants and binders,
for the disinfection of dental objects such as toothbrushes, dentures and the like contaminated by candida or parts of the body that have been attacked by candida.
19. Use in accordance with claim 18, characterized in that the composition is available in the form of a mixture of solids, especially a granulate or a tablet.
20. Use in accordance with claim 18, characterized in that the composition contains means for accelerating the dissolution (effervescent salts\u2014effervescents), for example a compound containing a carbonate or bicarbonate such as, for example sodium carbonate or sodium bicarbonate, and at least a stoichiometric quantity of acid for the production of a pH-value of less than 7 is contained in the composition.
21. Use in accordance with claim 18, characterized in that a hydrogen peroxosulphate compound is contained as oxidation means.
22. Use in accordance with claim 18, characterized in that the composition contains at least potassium hydrogen peroxosulphate as oxidizing agent, a saline chlorine compound, e.g. cooking salt (NaCl) as chloride compound and a carbon acid, preferably a mono-, di- or tricarbon acid, such as tartaric or citric acid, for the production of an acid pH-Value in the dissolved composition.
23. Use in accordance with claim 18, characterized in that the composition contains a binder and, optionally, aromatic and colouring substances and adjuvants such as substances for softening the water, fillers and the like, and is available in tablets or granulate form.
24. Use in accordance with claim 18, characterized in that the composition contains at least one tensed (surface-active substance or substance mixture).
25. Use in accordance with claim 18, characterized in that the composition is available in the form of a self-dissolving cleaning tablet.
26. Use in accordance with claim 25, characterized in that the composition or cleaning tablet has a homogeneous composition.
27. Use in accordance with claim 25, characterized in that the composition or the cleaning tablet is dissolved in an aqueous solution, preferable in water, in the presence of the object or body part that is to be disinfected.
28. Use in accordance with claim 18, characterized in that the binder is a copolymer of ethylene oxide and propylene oxide, polyvinyl pyrolidon or a copolymer of polyvinyl pyrolidon and vinyl acetate.
29. Use of a composition containing
at least one saline chloride compound in the form of salt of an alkaline or alkali earth metal and at least one suitable oxidizing agent for the in situ production of chlorine during the dissolution of the composition in an aqueous solution, where the oxidation potential of the oxidizing agent in aqueous solution is greater than the oxidizing potential of C11-C10 at least within the claimed pH-range,
an acid in such quantity that the composition dissolved. in a certain quantity of an aqueous solution produces a pH-value of less than 6, preferably less than 5.5 and even more preferably less than 5.0, as well as
whenever appropriate, a surface-active substance (tenside) or substance mixture, aromatic substances, adjuvants and binders,
for the production of a pharmaceutically effective means for treating body parts contaminated or affected by candida albicans.